Welcome to the Working Group on New TB Drugs Blog
Vienna 2010: Citizen News Service Correspondent Statement on IPT
Citizen News Service correspondent, Bobby Ramakant, reiterates the call from the Stop TB Working Group on TB/HIV to introduce Isoniazid prevention therapy to prevent the progression of latent TB infection to active disease. Effective IPT treatment reduces the development of active TB disease in 40-60% of patients. The content of this post originally appeared in an email sent to the Stop TB Health Dev mailing list.
This Week in TB R&D – July 20, 2010
On Friday, July 16th, the fourth annual New England TB Symposium took place at the Broad Institute, in Cambridge, Massachusetts. The symposium was in collaboration with the US-Japan Cooperative Medical Sciences Program: 45th Tuberculosis and Leprosy Research Conference which preceded the symposium at the Broad from July 13-15th.
A brief synopsis of some of the symposium [...]
Dual Infections Of TB And AIDS Make Each Harder To Treat
Tuberculosis infects nearly ten million people each year and kills nearly two million. It is primarily a lung disease that spreads easily among people with weakened immune systems. Sub-Saharan Africa is still the epicenter of the HIV/AIDS disaster, but it is also becoming the epicenter of tuberculosis.
GHC Conference: Changing Course: Stemming the Deadly Twin Epidemics of HIV and Tuberculosis
On May 20, the Center hosted a briefing with leading scientists and advocates on combating the dual epidemics of HIV and TB: Changing Course: Stemming the Deadly Twin Epidemics of HIV and Tuberculosis.
From HIV to Tuberculosis and Back Again: A Tale of Activism in 2 Pandemics
This article originally appeared in Clinical Infectious Diseases 2010;50:S260–S266.
Tuberculosis (TB) and human immunodeficiency virus (HIV) infections are the deadliest chronic infections globally. Although each is deadly alone, they are deadlier together, with TB causing one‐quarter of AIDS‐related deaths and HIV infecting at least 15% of patients with TB worldwide.
This week in TB R&D – March 2, 2010
This week we highlight two recent papers in TB R&D – TB and HIV treatment and PA-824.
Tuberculosis is the leading cause of the death in HIV positive individuals in the developing world. Major challenges exist in treating both diseases simultaneously as drug-drug interactions are common between the first-line of TB regimen and antiretroviral therapy (ART). [...]
This Week in TB R&D- 22 Feb 2010
A few recent reports track the progress being made by the Stop TB Partnership and TB research funding trends from 2005-2008. As global TB efforts increase in the areas of research, drug, vaccine and diagnostics development, greater emphasis has been placed upon funding.
Photographer David Rochkind’s Journey of Discovery
On my third day in Mumbai I met Rehmat Shekh, a 28 year old woman who is HIV postive and battling TB for the first time in her life. When I walked into her home, a small 8×10 foot room that she shares with 3 family members, she was on the floor, her gaunt frame [...]
